CU23241B7 - 2-fenil-1-(4(2-aminoetoxi)-benzil)-indol en combinacion con estrogenos - Google Patents

2-fenil-1-(4(2-aminoetoxi)-benzil)-indol en combinacion con estrogenos

Info

Publication number
CU23241B7
CU23241B7 CU20000255A CU20000255A CU23241B7 CU 23241 B7 CU23241 B7 CU 23241B7 CU 20000255 A CU20000255 A CU 20000255A CU 20000255 A CU20000255 A CU 20000255A CU 23241 B7 CU23241 B7 CU 23241B7
Authority
CU
Cuba
Prior art keywords
phenyl
aminoetoxi
strogens
benzil
indol
Prior art date
Application number
CU20000255A
Other languages
English (en)
Spanish (es)
Inventor
Barry Samuel Komm
James Harrison Pickar
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22151320&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CU23241(B7) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of CU23241B7 publication Critical patent/CU23241B7/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CU20000255A 1998-05-15 2000-11-15 2-fenil-1-(4(2-aminoetoxi)-benzil)-indol en combinacion con estrogenos CU23241B7 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7956198A 1998-05-15 1998-05-15

Publications (1)

Publication Number Publication Date
CU23241B7 true CU23241B7 (es) 2007-10-17

Family

ID=22151320

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20000255A CU23241B7 (es) 1998-05-15 2000-11-15 2-fenil-1-(4(2-aminoetoxi)-benzil)-indol en combinacion con estrogenos

Country Status (41)

Country Link
EP (1) EP1076558B1 (forum.php)
JP (3) JP2002515431A (forum.php)
KR (1) KR100620772B1 (forum.php)
CN (1) CN1230163C (forum.php)
AP (1) AP1424A (forum.php)
AR (1) AR020074A1 (forum.php)
AT (1) ATE245026T1 (forum.php)
AU (1) AU760378B2 (forum.php)
BE (1) BE2015C026I2 (forum.php)
BG (1) BG64783B1 (forum.php)
BR (1) BR9911040A (forum.php)
CA (1) CA2329530A1 (forum.php)
CU (1) CU23241B7 (forum.php)
CY (1) CY2015020I1 (forum.php)
CZ (1) CZ299334B6 (forum.php)
DE (1) DE69909616T2 (forum.php)
DK (1) DK1076558T3 (forum.php)
EA (1) EA005932B1 (forum.php)
EE (1) EE04262B1 (forum.php)
ES (1) ES2203131T3 (forum.php)
FR (1) FR15C0035I2 (forum.php)
GE (1) GEP20033079B (forum.php)
HR (1) HRP20000778B1 (forum.php)
HU (2) HU226587B1 (forum.php)
ID (1) ID26890A (forum.php)
IL (1) IL139130A (forum.php)
IN (1) IN192220B (forum.php)
LT (1) LTC1076558I2 (forum.php)
LU (1) LU92699I2 (forum.php)
NO (2) NO328129B1 (forum.php)
NZ (1) NZ508200A (forum.php)
OA (1) OA11552A (forum.php)
PL (1) PL194750B1 (forum.php)
PT (1) PT1076558E (forum.php)
SI (1) SI1076558T1 (forum.php)
SK (1) SK284666B6 (forum.php)
TR (1) TR200003377T2 (forum.php)
TW (1) TW565554B (forum.php)
UA (1) UA66861C2 (forum.php)
WO (1) WO1999059581A1 (forum.php)
ZA (1) ZA200006959B (forum.php)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
OA11552A (en) * 1998-05-15 2004-06-07 American Home Prod 2-Phenyl-1-Ä4-(2-Aminoethoxy)-BenzylÜ-Indole in Combination with Estrogens.
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
MX270786B (es) 1999-07-06 2009-10-08 Endorech Inc Metodos de tratamiento y/o supresion del incremento de peso.
US20020013327A1 (en) * 2000-04-18 2002-01-31 Lee Andrew G. Compositions and methods for treating female sexual dysfunction
AU2001273125A1 (en) * 2000-07-06 2002-01-21 American Home Products Corporation Combinations of bisphosphonates, estrogenic agents and optionally estrogens
US6455568B2 (en) 2000-07-06 2002-09-24 Wyeth Combination therapy for inhibiting sphincter incontinence
AU2001271784A1 (en) * 2000-07-06 2002-01-21 Wyeth Therapy for prosthesis-related bone degeneration
US6376486B1 (en) 2000-07-06 2002-04-23 American Home Products Corporation Methods of inhibiting sphincter incontinence
AU2001271781A1 (en) * 2000-07-06 2002-01-21 Wyeth Use of substituted indole compounds for treating sphincter incontinence
AU2001271785A1 (en) * 2000-07-06 2002-01-21 American Home Products Corporation Combinations of statins, estrogenic agents and optionally estrogens
DE10117441A1 (de) * 2001-04-03 2002-10-10 Schering Ag 1-Indolylderivate, deren Verwendung zur Herstellung von Arzneimitteln, ein Verfahren zur Herstellung der 1-Indolylderivate sowie 1-Indolylderivate enthaltende pharmzeutische Präparate
CA2448235A1 (en) 2001-07-31 2003-02-13 Pfizer Products Inc. Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins
KR100470274B1 (ko) 2002-11-08 2005-02-05 진 장 덮개층을 이용한 비정질 물질의 상 변화 방법
US7781478B2 (en) 2004-07-14 2010-08-24 Ptc Therapeutics, Inc. Methods for treating hepatitis C
FR2880625B1 (fr) * 2005-01-07 2007-03-09 Sanofi Aventis Sa Derives de n-(heteroaryl)-1h-indole-2-carboxamides, leur preparation et leur application en therapeutique
HUE025471T2 (hu) 2008-04-16 2016-03-29 Karobio Ab Új ösztrogén receptor ligandumok
AR072297A1 (es) * 2008-06-27 2010-08-18 Novartis Ag Derivados de indol-2-il-piridin-3-ilo, composicion farmaceutica que los comprende y su uso en medicamentos para el tratamiento de enfermedades mediadas por la sintasa aldosterona.
GB201113538D0 (en) 2011-08-04 2011-09-21 Karobio Ab Novel estrogen receptor ligands
CN102690225B (zh) * 2012-04-11 2014-12-24 南京友杰医药科技有限公司 巴多昔芬的合成方法
CN103709090A (zh) * 2014-01-16 2014-04-09 江苏万特制药有限公司 醋酸巴多昔芬的制备方法及其关键中间体
CN103739540B (zh) * 2014-01-20 2016-05-04 华润赛科药业有限责任公司 一种醋酸巴多昔芬中间体的制备方法
CN105669518B (zh) * 2014-12-04 2019-06-04 上海医药集团股份有限公司 醋酸巴多昔芬及其a晶型的制备方法
CA3085333A1 (en) * 2017-12-15 2019-06-20 Bristol-Myers Squibb Company Substituted indole ether compounds
IT201800006562A1 (it) * 2018-06-21 2019-12-21 Procedimento e intermedi utili per la preparazione di indoli
EP4122925A4 (en) * 2020-03-17 2024-04-17 Medshine Discovery Inc. PROTEOLYSIS REGULATOR AND METHOD OF USE

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4729999A (en) * 1984-10-12 1988-03-08 Bcm Technologies Antiestrogen therapy for symptoms of estrogen deficiency
AU665690B2 (en) * 1992-05-08 1996-01-11 Otsuka Pharmaceutical Factory, Inc. Indole derivative
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
GB9326332D0 (en) * 1993-12-23 1994-02-23 Karo Bio Indole derivatives
DE4426625A1 (de) * 1994-07-27 1996-03-14 Schering Ag 2-Phenylindole, Verfahren zu deren Herstellung, diese enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
SK281737B6 (sk) * 1996-04-19 2001-07-10 American Home Products Corporation 2-fenylindolové zlúčeniny, farmaceutický prostriedok s ich obsahom a ich použitie
TW397821B (en) * 1996-04-19 2000-07-11 American Home Produits Corp 3-[4-(2-phenyl-indole-1-ylmethyl)-phenyl]-acrylamides and 2-phenyl-1-[4-(amino-1-yl-alk-1-ynyl)-benzyl]-1H-indol-5-ol as well as pharmaceutical compositions of estrogenic agents thereof
WO1998001443A1 (en) * 1996-07-09 1998-01-15 Smithkline Beecham S.P.A. Indole derivatives for the treatment of osteoporosis
US5672609A (en) * 1996-07-18 1997-09-30 Eli Lilly And Company Pyridine compounds, intermediates compositions and methods of use
SI1025077T1 (sl) * 1997-10-15 2007-06-30 Wyeth Corp Novi ariloksi-alkil-dialkilamini
CA2308069A1 (en) * 1997-10-28 1999-05-06 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
ID24568A (id) * 1997-11-06 2000-07-27 American Home Prod Kontrasepsi oral yang mengandung anti-estrogen plus progestin
OA11552A (en) * 1998-05-15 2004-06-07 American Home Prod 2-Phenyl-1-Ä4-(2-Aminoethoxy)-BenzylÜ-Indole in Combination with Estrogens.

Also Published As

Publication number Publication date
LU92699I2 (fr) 2015-06-24
BG104930A (en) 2001-07-31
CN1230163C (zh) 2005-12-07
TR200003377T2 (tr) 2001-03-21
KR20010043641A (ko) 2001-05-25
AU3894499A (en) 1999-12-06
LTC1076558I2 (lt) 2016-11-10
HUP0103096A2 (hu) 2002-05-29
JP2002515431A (ja) 2002-05-28
BR9911040A (pt) 2001-02-13
SK17202000A3 (sk) 2001-07-10
HRP20000778B1 (en) 2004-10-31
IN192220B (forum.php) 2004-03-20
NO328129B1 (no) 2009-12-14
EE04262B1 (et) 2004-04-15
DE69909616D1 (de) 2003-08-21
TW565554B (en) 2003-12-11
NO20005770L (no) 2001-01-12
PT1076558E (pt) 2003-11-28
NZ508200A (en) 2003-09-26
HU226587B1 (en) 2009-04-28
SK284666B6 (sk) 2005-08-04
DE69909616T2 (de) 2004-06-17
AP2000001970A0 (en) 2000-12-31
NO2015015I2 (no) 2015-06-02
BG64783B1 (bg) 2006-04-28
BE2015C026I2 (en) 2018-08-24
HUS1500023I1 (hu) 2017-03-28
NO2015015I1 (no) 2015-06-02
UA66861C2 (uk) 2004-06-15
EP1076558A1 (en) 2001-02-21
PL194750B1 (pl) 2007-06-29
DK1076558T3 (da) 2003-11-03
JP2009019042A (ja) 2009-01-29
IL139130A0 (en) 2001-11-25
SI1076558T1 (en) 2003-10-31
JP2014159472A (ja) 2014-09-04
IL139130A (en) 2005-11-20
FR15C0035I1 (forum.php) 2015-06-26
OA11552A (en) 2004-06-07
AU760378B2 (en) 2003-05-15
ATE245026T1 (de) 2003-08-15
CZ20004254A3 (cs) 2001-12-12
AP1424A (en) 2005-06-06
EA200001193A1 (ru) 2001-12-24
FR15C0035I2 (fr) 2015-08-28
EP1076558B1 (en) 2003-07-16
KR100620772B1 (ko) 2006-09-13
AR020074A1 (es) 2002-04-10
CN1326347A (zh) 2001-12-12
NO20005770D0 (no) 2000-11-14
HK1031691A1 (en) 2001-06-22
CY2015020I1 (el) 2020-05-29
ES2203131T3 (es) 2004-04-01
JP5872624B2 (ja) 2016-03-01
GEP20033079B (en) 2003-10-27
CZ299334B6 (cs) 2008-06-25
EA005932B1 (ru) 2005-08-25
JP5607871B2 (ja) 2014-10-15
WO1999059581A1 (en) 1999-11-25
CA2329530A1 (en) 1999-11-25
ID26890A (id) 2001-02-15
HUP0103096A3 (en) 2002-11-28
ZA200006959B (en) 2001-11-27
EE200000652A (et) 2002-04-15
HRP20000778A2 (en) 2001-06-30
PL345268A1 (en) 2001-12-03

Similar Documents

Publication Publication Date Title
CU23241B7 (es) 2-fenil-1-(4(2-aminoetoxi)-benzil)-indol en combinacion con estrogenos
AR019503A1 (es) Utilizacion de derivados sustituidos en 3 del estilbeno como agentes activos desodorantes en las composiciones cosmeticas
ES2186015T3 (es) Derivados de 2-(purin-9-il)-tetrahidrofuran-3,4-diol.
ES2056190T3 (es) Derivados de 4(4-fenil-1-piperazinil)fenoles, inhibidores de 5-lipoxigenasa.
ES2079589T3 (es) Agentes farmaceuticos.
ATE409496T1 (de) Hautdesodorierende und desinfizierende zubereitung
SV1999000016A (es) Derivados de 2-(purin-9-il-tetrahidrofuran-3,4-diol ref. pg3443/sv
AR028948A1 (es) Compuestos novedosos
PT1117440E (pt) Composicoes farmaceuticas que contem paclitaxel
CR9879A (es) Moduladores de ccr5 (divisional de la solicitud n° 6392)
AR011116A1 (es) Compuesto derivado de n-hidroxi-beta-sulfonil propionamida y composicion farmaceutica que lo contiene
PT1263724E (pt) Novos compostos
YU7797A (sh) Kombinovana terapija za osteoporozu
MX9702865A (es) Agentes estrogenicos.
ES2113127T3 (es) Derivado de androstenona.
ES2195189T3 (es) Benzonaftiridinas como agentes terapeuticos bronquiales.
ECSP055609A (es) "Uso de inhibidores de la IkB-quinasa para el tratamiento del dolor"
ATE273690T1 (de) Zusammensetzung zur hautdesinfizierung
ES2151083T3 (es) Composiciones orales que contienen ondansetron.
PT889886E (pt) Novas fenantridinas substituidas na posicao 6
CO5080743A1 (es) Benzocicloheptenos, un procedimiento para su preparacion y las composiciones farmaceuticas que los contienen. .
GT200100153A (es) Compuestos de 1,4-dihidropiridina como antagonistas de bradiquinina.
GT199800106A (es) Azetidinas.
BR0008509A (pt) Composição farmacêutica oral estabilizada contendo iodeto e iodato e método
AR021843A1 (es) Derivados de propanolamina sustituidos con heterociclos, procedimiento para su preparacion, y su utilizacion.

Legal Events

Date Code Title Description
FD Lapse (for not paying fees)